Intrahepatic Cholestasis of Pregnancy: Toward Improving Perinatal Outcome
- PMID: 34524639
- DOI: 10.1007/s43032-021-00740-x
Intrahepatic Cholestasis of Pregnancy: Toward Improving Perinatal Outcome
Abstract
Intrahepatic cholestasis of pregnancy (ICP) is associated with poor perinatal outcomes in some women such as preterm delivery and fetal demise. Ursodeoxycholic acid (UDCA) is the main therapeutic agent for ICP, but recent evidence failed to show an impact on most perinatal outcomes. Our objective is to summarize the latest evidence in the management of ICP, with a focus on perinatal outcome. We propose a practical approach that combines pharmacotherapy with biochemical and fetal testing, as well as delivery planning.
Keywords: Bile acid; Cholestasis; Hepatic disease; Pregnancy.
© 2021. Society for Reproductive Investigation.
References
-
- Marschall HU, WikströmShemer E, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study. Hepatology. 2013;58(4):1385–91. https://doi.org/10.1002/hep.26444 . - DOI - PubMed
-
- Lee RH, Goodwin TM, Greenspoon J, Incerpi M. The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol. 2006;26(9):527–32. https://doi.org/10.1038/sj.jp.7211545 . - DOI - PubMed
-
- Abedin P, Weaver JB, Egginton E. Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health 4:35–37, 1999. Germain A, Carvajal JA, Glasinovic JC, et al.: Intrahepatic cholestasis of pregnancy. An intriguing pregnancy specific disorder. J Soc Gynecol Invest. 2002;9:10–4.
-
- Williamson C, Geenes V. Intrahepatic cholestasis of pregnancy. Obstet Gynecol. 2014;124(1):120–33. https://doi.org/10.1097/AOG.0000000000000346 . - DOI - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical